The expression level of FTO mRNA was significantly down-regulated in stageII-IV of bladder urothelial carcinoma tissues compared with the normal controls (p < 0.0001 for stageII, p = 0.0083 for stageIII and p = 0.0009 for stageIV, Fig. 2). Here, FTO is linked to bladder transitional cell carcinoma.